{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:22:07Z","timestamp":1793992927833,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical and Health Key project of Xiamen","award":["3502Z20191106"],"award-info":[{"award-number":["3502Z20191106"]}]},{"name":"Key Project of Natural Science Foundation of Fujian Province","award":["2022J02056"],"award-info":[{"award-number":["2022J02056"]}]},{"name":"Key Project of Natural Science Foundation of Fujian Province","award":["2023D001"],"award-info":[{"award-number":["2023D001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871961"],"award-info":[{"award-number":["81871961"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72714-3","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T16:01:54Z","timestamp":1727798514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The activation of the Notch signaling pathway by UBE2C promotes the proliferation and metastasis of hepatocellular carcinoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Ping","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhe","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengrong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"72714_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin.70, 7\u201330. https:\/\/doi.org\/10.3322\/caac.21590 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"72714_CR2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10555-014-9522-4","volume":"33","author":"SH Ryu","year":"2014","unstructured":"Ryu, S. H., Jang, M. K., Kim, W. J., Lee, D. & Chung, Y. H. Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicine. Cancer Metastasis Rev.33, 965\u2013980. https:\/\/doi.org\/10.1007\/s10555-014-9522-4 (2014).","journal-title":"Cancer Metastasis Rev."},{"key":"72714_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert, A. W., Pattabiraman, D. R. & Weinberg, R. A. Emerging biological principles of metastasis. Cell168, 670\u2013691. https:\/\/doi.org\/10.1016\/j.cell.2016.11.037 (2017).","journal-title":"Cell"},{"key":"72714_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrm.2017.83","volume":"19","author":"M Rape","year":"2018","unstructured":"Rape, M. Ubiquitylation at the crossroads of development and disease. Nat. Rev. Mol. Cell Biol.19, 59\u201370. https:\/\/doi.org\/10.1038\/nrm.2017.83 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"72714_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/cr.2016.40","volume":"26","author":"H Hu","year":"2016","unstructured":"Hu, H. & Sun, S. C. Ubiquitin signaling in immune responses. Cell Res.26, 457\u2013483. https:\/\/doi.org\/10.1038\/cr.2016.40 (2016).","journal-title":"Cell Res."},{"key":"72714_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nature05734","volume":"446","author":"SK Reddy","year":"2007","unstructured":"Reddy, S. K., Rape, M., Margansky, W. A. & Kirschner, M. W. Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation. Nature446, 921\u2013925. https:\/\/doi.org\/10.1038\/nature05734 (2007).","journal-title":"Nature"},{"key":"72714_CR7","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1073\/pnas.94.6.2362","volume":"94","author":"FM Townsley","year":"1997","unstructured":"Townsley, F. M., Aristarkhov, A., Beck, S., Hershko, A. & Ruderman, J. V. Dominant-negative cyclin-selective ubiquitin carrier protein E2-C\/UbcH10 blocks cells in metaphase. Proc. Natl. Acad. Sci. U.S.A.94, 2362\u20132367. https:\/\/doi.org\/10.1073\/pnas.94.6.2362 (1997).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"72714_CR8","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1038\/sj.onc.1207861","volume":"23","author":"KW Wagner","year":"2004","unstructured":"Wagner, K. W. et al. Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin. Oncogene23, 6621\u20136629. https:\/\/doi.org\/10.1038\/sj.onc.1207861 (2004).","journal-title":"Oncogene"},{"key":"72714_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1158\/1541-7786.MCR-19-0561","volume":"18","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. UBE2C is upregulated by estrogen and promotes epithelial-mesenchymal transition via p53 in endometrial cancer. Mol. Cancer Res.18, 204\u2013215. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0561 (2020).","journal-title":"Mol. Cancer Res."},{"key":"72714_CR10","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.7150\/thno.32738","volume":"9","author":"D Jin","year":"2019","unstructured":"Jin, D. et al. UBE2C, directly targeted by miR-548e-5p, increases the cellular growth and invasive abilities of cancer cells interacting with the EMT marker protein zinc finger E-box binding homeobox 1\/2 in NSCLC. Theranostics9, 2036\u20132055. https:\/\/doi.org\/10.7150\/thno.32738 (2019).","journal-title":"Theranostics"},{"key":"72714_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/mc.22322","volume":"55","author":"NA Cacciola","year":"2016","unstructured":"Cacciola, N. A. et al. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients. Mol. Carcinog.55, 793\u2013807. https:\/\/doi.org\/10.1002\/mc.22322 (2016).","journal-title":"Mol. Carcinog."},{"key":"72714_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/pros.23248","volume":"77","author":"CH Lee","year":"2017","unstructured":"Lee, C. H. et al. Transcript levels of androgen receptor variant 7 and ubiquitin-conjugating enzyme 2\u00a0C in hormone sensitive prostate cancer and castration-resistant prostate cancer. Prostate77, 60\u201371. https:\/\/doi.org\/10.1002\/pros.23248 (2017).","journal-title":"Prostate"},{"key":"72714_CR13","doi-asserted-by":"publisher","first-page":"BSR20182384","DOI":"10.1042\/BSR20182384","volume":"39","author":"Y Xiong","year":"2019","unstructured":"Xiong, Y. et al. UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells. Biosci. Rep.39, BSR20182384. https:\/\/doi.org\/10.1042\/BSR20182384 (2019).","journal-title":"Biosci. Rep."},{"key":"72714_CR14","doi-asserted-by":"publisher","first-page":"162434","DOI":"10.1172\/JCI162434","volume":"133","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. The UBE2C\/CDH1\/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells. J. Clin. Invest.133, 162434. https:\/\/doi.org\/10.1172\/JCI162434 (2023).","journal-title":"J. Clin. Invest."},{"key":"72714_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1083\/jcb.200906147","volume":"188","author":"JH van Ree","year":"2010","unstructured":"van Ree, J. H., Jeganathan, K. B., Malureanu, L. & van Deursen, J. M. Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation. J. Cell Biol.188, 83\u2013100. https:\/\/doi.org\/10.1083\/jcb.200906147 (2010).","journal-title":"J. Cell Biol."},{"key":"72714_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ebiom.2018.08.001","volume":"35","author":"J Guo","year":"2018","unstructured":"Guo, J. et al. The miR 495-UBE2C-ABCG2\/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells. EBioMedicine35, 204\u2013221. https:\/\/doi.org\/10.1016\/j.ebiom.2018.08.001 (2018).","journal-title":"EBioMedicine"},{"key":"72714_CR17","doi-asserted-by":"publisher","first-page":"8607859","DOI":"10.1155\/2019\/8607859","volume":"2019","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. UBE2C induces cisplatin resistance via ZEB1\/2-dependent upregulation of ABCG2 and ERCC1 in NSCLC cells. J. Oncol.2019, 8607859. https:\/\/doi.org\/10.1155\/2019\/8607859 (2019).","journal-title":"J. Oncol."},{"key":"72714_CR18","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.7150\/jca.26847","volume":"10","author":"Q Huang","year":"2019","unstructured":"Huang, Q., Li, J., Zheng, J. & Wei, A. The carcinogenic role of the notch signaling pathway in the development of hepatocellular carcinoma. J. Cancer10, 1570\u20131579. https:\/\/doi.org\/10.7150\/jca.26847 (2019).","journal-title":"J. Cancer"},{"key":"72714_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","volume":"34","author":"O Meurette","year":"2018","unstructured":"Meurette, O. & Mehlen, P. Notch signaling in the tumor microenvironment. Cancer Cell34, 536\u2013548. https:\/\/doi.org\/10.1016\/j.ccell.2018.07.009 (2018).","journal-title":"Cancer Cell"},{"key":"72714_CR20","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41374-018-0050-7","volume":"98","author":"S Zhang","year":"2018","unstructured":"Zhang, S. et al. Ubiquitin-specific protease 11 serves as a marker of poor prognosis and promotes metastasis in hepatocellular carcinoma. Lab. Invest.98, 883\u2013894. https:\/\/doi.org\/10.1038\/s41374-018-0050-7 (2018).","journal-title":"Lab. Invest."},{"key":"72714_CR21","doi-asserted-by":"publisher","first-page":"8704","DOI":"10.1038\/ncomms9704","volume":"6","author":"B Wang","year":"2015","unstructured":"Wang, B. et al. POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation. Nat. Commun.6, 8704. https:\/\/doi.org\/10.1038\/ncomms9704 (2015).","journal-title":"Nat. Commun."},{"key":"72714_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2019.10.025","volume":"469","author":"J Lv","year":"2020","unstructured":"Lv, J. et al. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2. Cancer Lett.469, 22\u201334. https:\/\/doi.org\/10.1016\/j.canlet.2019.10.025 (2020).","journal-title":"Cancer Lett."},{"key":"72714_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13578-021-00588-3","volume":"11","author":"S Yuan","year":"2021","unstructured":"Yuan, S. et al. Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line. Cell. Biosci.11, 75. https:\/\/doi.org\/10.1186\/s13578-021-00588-3 (2021).","journal-title":"Cell. Biosci."},{"key":"72714_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.omtn.2017.10.018","volume":"9","author":"CR Xie","year":"2017","unstructured":"Xie, C. R. et al. Long noncoding RNA HCAL facilitates the growth and metastasis of hepatocellular carcinoma by acting as a ceRNA of LAPTM4B. Mol. Ther. Nucleic Acids9, 440\u2013451. https:\/\/doi.org\/10.1016\/j.omtn.2017.10.018 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"72714_CR25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1086\/381506","volume":"74","author":"A Joutel","year":"2004","unstructured":"Joutel, A., Monet, M., Domenga, V., Riant, F. & Tournier-Lasserve, E. Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect jagged1 binding and Notch3 activity via the RBP\/JK signaling pathway. Am. J. Hum. Genet.74, 338\u2013347. https:\/\/doi.org\/10.1086\/381506 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"72714_CR26","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ccr.2014.03.010","volume":"25","author":"JH Yuan","year":"2014","unstructured":"Yuan, J. H. et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell.25, 666\u2013681. https:\/\/doi.org\/10.1016\/j.ccr.2014.03.010 (2014).","journal-title":"Cancer Cell."},{"key":"72714_CR27","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1084\/jem.20071082","volume":"204","author":"KG Leong","year":"2007","unstructured":"Leong, K. G. et al. Jagged1-mediated notch activation induces epithelial-to-mesenchymal transition through slug-induced repression of E-cadherin. J. Exp. Med.204, 2935\u20132948. https:\/\/doi.org\/10.1084\/jem.20071082 (2007).","journal-title":"J. Exp. Med."},{"key":"72714_CR28","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1073\/pnas.0802047105","volume":"105","author":"C Sahlgren","year":"2008","unstructured":"Sahlgren, C., Gustafsson, M. V., Jin, S., Poellinger, L. & Lendahl, U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. U.S.A.105, 6392\u20136397. https:\/\/doi.org\/10.1073\/pnas.0802047105 (2008).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"72714_CR29","doi-asserted-by":"publisher","first-page":"10185","DOI":"10.2147\/IJGM.S341379","volume":"14","author":"Z Yang","year":"2021","unstructured":"Yang, Z. et al. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM may be potential therapeutic targets for hepatocellular carcinoma using integrated bioinformatic analysis. Int. J. Gen. Med.14, 10185\u201310194. https:\/\/doi.org\/10.2147\/IJGM.S341379 (2021).","journal-title":"Int. J. Gen. Med."},{"key":"72714_CR30","doi-asserted-by":"publisher","first-page":"368504211029429","DOI":"10.1177\/00368504211029429","volume":"104","author":"J Wang","year":"2021","unstructured":"Wang, J. et al. Global analysis of gene expression signature and diagnostic\/prognostic biomarker identification of hepatocellular carcinoma. Sci. Prog.104, 368504211029429. https:\/\/doi.org\/10.1177\/00368504211029429 (2021).","journal-title":"Sci. Prog."},{"key":"72714_CR31","doi-asserted-by":"publisher","first-page":"647353","DOI":"10.3389\/fgene.2021.647353","volume":"12","author":"R Huang","year":"2021","unstructured":"Huang, R. et al. Identification of hub genes and their correlation with immune infiltration cells in hepatocellular carcinoma based on GEO and TCGA databases. Front. Genet.12, 647353. https:\/\/doi.org\/10.3389\/fgene.2021.647353 (2021).","journal-title":"Front. Genet."},{"key":"72714_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-3-030-55031-8_6","volume":"1287","author":"K Kawaguchi","year":"2021","unstructured":"Kawaguchi, K. & Kaneko, S. Notch signaling and liver cancer. Adv. Exp. Med. Biol.1287, 69\u201380. https:\/\/doi.org\/10.1007\/978-3-030-55031-8_6 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"72714_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16815","author":"N Sachan","year":"2023","unstructured":"Sachan, N., Sharma, V., Mutsuddi, M. & Mukherjee, A. Notch signalling: multifaceted role in development and disease. FEBS J.https:\/\/doi.org\/10.1111\/febs.16815 (2023).","journal-title":"FEBS J."},{"key":"72714_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-023-01439-z","volume":"16","author":"X Li","year":"2023","unstructured":"Li, X. et al. The Notch signaling pathway: a potential target for cancer immunotherapy. J. Hematol. Oncol.16, 45. https:\/\/doi.org\/10.1186\/s13045-023-01439-z (2023).","journal-title":"J. Hematol. Oncol."},{"key":"72714_CR35","doi-asserted-by":"publisher","first-page":"12131680","DOI":"10.3390\/cells12131680","volume":"12","author":"P Scalia","year":"2023","unstructured":"Scalia, P., Williams, S. J., Suma, A. & Carnevale, V. The DTX protein family: an emerging set of E3 ubiquitin ligases in cancer.. Cells12, 12131680. https:\/\/doi.org\/10.3390\/cells12131680 (2023).","journal-title":"Cells"},{"key":"72714_CR36","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1136\/gutjnl-2017-314061","volume":"67","author":"W Kim","year":"2018","unstructured":"Kim, W. et al. Hepatic hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma. Gut67, 1692\u20131703. https:\/\/doi.org\/10.1136\/gutjnl-2017-314061 (2018).","journal-title":"Gut"},{"key":"72714_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13046-018-0892-2","volume":"37","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Yes-associated protein (YAP) binds to HIF-1alpha and sustains HIF-1alpha protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress. J. Exp. Clin. Cancer Res.37, 216. https:\/\/doi.org\/10.1186\/s13046-018-0892-2 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"72714_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13046-020-1523-2","volume":"39","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids. J. experimental Clin. Cancer Res.39, 22. https:\/\/doi.org\/10.1186\/s13046-020-1523-2 (2020).","journal-title":"J. experimental Clin. Cancer Res."},{"key":"72714_CR39","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2147\/CMAR.S230466","volume":"12","author":"L Mi","year":"2020","unstructured":"Mi, L. & Kuang, H. Melatonin regulates cisplatin resistance and glucose metabolism through hippo signaling in hepatocellular carcinoma cells. Cancer Manag. Res.12, 1863\u20131874. https:\/\/doi.org\/10.2147\/CMAR.S230466 (2020).","journal-title":"Cancer Manag. Res."},{"key":"72714_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1172\/JCI88486","volume":"127","author":"W Kim","year":"2017","unstructured":"Kim, W. et al. Hippo signaling interactions with Wnt\/beta-catenin and notch signaling repress liver tumorigenesis. J. Clin. Investig.127, 137\u2013152. https:\/\/doi.org\/10.1172\/JCI88486 (2017).","journal-title":"J. Clin. Investig."},{"key":"72714_CR41","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/leu.2013.183","volume":"28","author":"V Agnusdei","year":"2014","unstructured":"Agnusdei, V. et al. Therapeutic antibody targeting of notch1 in T-acute lymphoblastic leukemia xenografts. Leukemia28, 278\u2013288. https:\/\/doi.org\/10.1038\/leu.2013.183 (2014).","journal-title":"Leukemia"},{"key":"72714_CR42","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1158\/1078-0432.CCR-14-2808","volume":"21","author":"WC Yen","year":"2015","unstructured":"Yen, W. C. et al. Targeting notch signaling with a Notch2\/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency. Clin. Cancer Res.21, 2084\u20132095. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2808 (2015).","journal-title":"Clin. Cancer Res."},{"key":"72714_CR43","doi-asserted-by":"publisher","first-page":"7672","DOI":"10.1158\/0008-5472.CAN-09-1843","volume":"69","author":"L Luistro","year":"2009","unstructured":"Luistro, L. et al. Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. Cancer Res.69, 7672\u20137680. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1843 (2009).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72714-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72714-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72714-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T16:04:48Z","timestamp":1727798688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72714-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72714"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72714-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"26 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval for the study was granted by the Ethics Committee of Zhongshan Hospital of Xiamen University (No. 2018-0334), and the patients involved provided informed consent. The Animal Care and Use Committee of Xiamen University granted approval for the animal study. All animal experiments complied with the ARRIVE guidelines and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"22859"}}